Quest PharmaTech (CVE:QPT) Trading Down 33.3% – Here’s What Happened

Quest PharmaTech Inc. (CVE:QPT) shares dropped 33.3% during trading on Friday . The company traded as low as C$0.02 and last traded at C$0.02. Approximately 1,200,000 shares were traded during mid-day trading, an increase of 1,995% from the average daily volume of 57,275 shares. The stock had previously closed at C$0.03.

Quest PharmaTech Stock Performance

The company has a 50 day simple moving average of C$0.03 and a 200-day simple moving average of C$0.03. The company has a debt-to-equity ratio of 4.35, a current ratio of 0.40 and a quick ratio of 0.52. The stock has a market cap of C$3.38 million, a P/E ratio of 0.67 and a beta of -0.09.

About Quest PharmaTech

Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class.